14.5 Returning to Dialysis After Graft Failure

Recognize the Transition

A transplanted kidney may lose function through rejection, chronic injury, recurrent disease, infection, vascular problems or other causes. Some deterioration is treatable; some progresses to dialysis dependence. Return to dialysis is therefore a clinical transition rather than a single creatinine threshold. The treating team evaluates reversibility, symptoms, electrolytes, volume and the need for urgent kidney replacement therapy.

The dialysis nurse should know the graft history, recent treatment, current immunosuppression, infection status and transplant-team contacts. Do not relabel every creatinine rise as permanent graft failure. Acute reversible problems can coexist with chronic dysfunction. Conversely, a patient with dangerous hyperkalemia or pulmonary edema may need immediate support while the cause is investigated.

Access and Prescription Planning

Assess whether an old fistula or graft remains patent and usable. Years without dialysis do not guarantee that it can safely support two-needle treatment now. Inspect the skin, thrill, bruit and distal circulation and obtain the appropriate access assessment. If urgent catheter placement is needed, preserve future options through the individualized Life-Plan.

The previous dialysis prescription may be obsolete. Current body composition, residual urine, cardiac state, anemia, medications and metabolic needs differ. Verify a new order rather than copying the regimen from before transplantation. A target weight from several years earlier can be dangerously low or high. Begin with current examination and a cautious, reassessed fluid plan.

Immunosuppression Requires Coordination

After graft failure, continued immunosuppression may preserve residual function or limit sensitization in selected patients, but it also creates infection and other risks. Withdrawal can affect inflammation, graft intolerance and future transplant compatibility. The balance depends on retransplant plans, residual graft function, infection, malignancy and overall goals. The transplant and nephrology teams determine the regimen and taper.

Do not independently stop tacrolimus, mycophenolate or steroids because dialysis has resumed. Do not assume that every patient must continue all therapy indefinitely either. Confirm the explicit plan and responsible prescriber. Long-term corticosteroid withdrawal may also require careful management. Medication reconciliation is especially important when hospital, transplant and dialysis lists disagree.

Residual Function and Graft Symptoms

Urine output may continue despite inadequate filtration, influencing fluid allowance and dialysis needs. Track it accurately and assess trends. A patient who produces urine may still require dialysis for solute control. Diuretics or other prescribed treatment can affect output, so distinguish observed volume from presumed recovery.

Graft pain, fever, hematuria or systemic symptoms need evaluation for infection, rejection-related inflammation or other causes. Graft removal is not automatic for every failed transplant; the specialist team determines indications. Treat fever as potentially urgent, especially while immunosuppression continues. Do not attribute all inflammatory symptoms to 'the old kidney' without investigation.

Rebuild the Ongoing Care Plan

Diet advice often changes after returning to dialysis, but it remains individualized. A transplant-era potassium or fluid plan may no longer fit. Review anticoagulation and bleeding risk, including recent biopsy or surgery. Evaluate vaccinations and infection precautions through the appropriate teams rather than assuming the patient now has the same immune status as every maintenance-HD patient.

Emotional and Practical Support

Graft failure can feel like a loss of independence or a personal failure. Ask how the patient is coping and avoid language that assigns blame without evidence. Address depression, uncertainty, transport, work and caregiver strain. A patient who remembers dialysis techniques may still need retraining after years away, particularly with changed machines or access. Prior experience should be acknowledged but verified.

Discuss options including home therapy and retransplant evaluation when appropriate. Not every patient wants or qualifies for another transplant, and counseling should respect informed preferences. Transfusion, infection and medication decisions may affect future sensitization and readiness; communicate them to the transplant program. Immediate safety remains paramount and is not sacrificed to a hypothetical future offer.

Scenario

A patient returns with pulmonary edema after progressive graft dysfunction. The old target weight is six kilograms below the current weight, but the patient has gained tissue mass over several years and is hypotensive. The nurse reports the current examination, urine output and medication list and confirms an individualized prescription. Removing six liters solely to reach the historical number would ignore the patient's present physiology.

The transition succeeds when urgent needs are controlled and the longer-term plan is coherent. Clear responsibility for immunosuppression, access and follow-up prevents the patient from receiving contradictory instructions from different teams.

Source: KDIGO transplant-recipient guidance.